Photons Induce Vesicular Exocytotic Release of Glutamate in a Power-Dependent Way
暂无分享,去创建一个
M. Marcoli | A. Diaspro | S. Benedicenti | G. Maura | S. Amato | C. Cervetto | A. Amaroli | E. Gatta | A. Signore
[1] I. Gibson,et al. Laser subtractive and laser powder bed fusion of metals: review of process and production features , 2023, Rapid Prototyping Journal.
[2] Sufang Tang,et al. Rapid-acting antidepressants targeting modulation of the glutamatergic system: clinical and preclinical evidence and mechanisms , 2022, General Psychiatry.
[3] Michael R Hamblin,et al. Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022 , 2022, Frontiers in Oncology.
[4] Jason H. Huang,et al. Transcranial near-infrared light in treatment of neurodegenerative diseases , 2022, Frontiers in Pharmacology.
[5] A. Benabid,et al. The effect of photobiomodulation on the brain during wakefulness and sleep , 2022, Frontiers in Neuroscience.
[6] E. Hascup,et al. Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease , 2022, Frontiers in Aging.
[7] R. McIntyre. Rapid-acting antidepressants in psychiatry: psychedelics, episodic treatments, innovation, and clarion call for methodologic rigor in drug development , 2022, Expert opinion on drug safety.
[8] Douglas W. Barrett,et al. Photobiomodulation of Cytochrome c Oxidase by Chronic Transcranial Laser in Young and Aged Brains , 2022, Frontiers in Neuroscience.
[9] C. Simon,et al. Photons guided by axons may enable backpropagation-based learning in the brain , 2022, bioRxiv.
[10] J. Rizo. Molecular Mechanisms Underlying Neurotransmitter Release. , 2022, Annual review of biophysics.
[11] Quanguang Zhang,et al. Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model , 2022, Theranostics.
[12] S. Benedicenti,et al. A Narrative Review on Oral and Periodontal Bacteria Microbiota Photobiomodulation, through Visible and Near-Infrared Light: From the Origins to Modern Therapies , 2022, International journal of molecular sciences.
[13] J. Mitrofanis,et al. A Perspective on the Potential of Opsins as an Integral Mechanism of Photobiomodulation: It's Not Just the Eyes. , 2021, Photobiomodulation, photomedicine, and laser surgery.
[14] P. Arany. Photobiomodulation-Activated Latent Transforming Growth Factor-β1: A Critical Clinical Therapeutic Pathway and an Endogenous Optogenetic Tool for Discovery. , 2021, Photobiomodulation, photomedicine, and laser surgery.
[15] Wensi Wu,et al. Transcranial Photobiomodulation Therapy Ameliorates Perioperative Neurocognitive Disorder Through Modulation of Mitochondrial Function in Aged Mice , 2021, Neuroscience.
[16] W. Bunney,et al. Rapid-acting antidepressants and the circadian clock , 2021, Neuropsychopharmacology.
[17] Dong-Sun Han,et al. Photobiomodulation Promotes Hippocampal CA1 NSC Differentiation Toward Neurons and Facilitates Cognitive Function Recovery Involving NLRP3 Inflammasome Mitigation Following Global Cerebral Ischemia , 2021, Frontiers in Cellular Neuroscience.
[18] D. Nosi,et al. NIR Laser Photobiomodulation Induces Neuroprotection in an In Vitro Model of Cerebral Hypoxia/Ischemia , 2021, Molecular Neurobiology.
[19] S. Benedicenti,et al. Improving Consistency of Photobiomodulation Therapy: A Novel Flat-Top Beam Hand-Piece versus Standard Gaussian Probes on Mitochondrial Activity , 2021, International journal of molecular sciences.
[20] C. Zarate,et al. Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status , 2021, CNS Drugs.
[21] S. Benedicenti,et al. Mitochondrial Bioenergetic, Photobiomodulation and Trigeminal Branches Nerve Damage, What’s the Connection? A Review , 2021, International journal of molecular sciences.
[22] S. Benedicenti,et al. Experimental and Clinical Applications of Red and Near-Infrared Photobiomodulation on Endothelial Dysfunction: A Review , 2021, Biomedicines.
[23] K. K. Mahato,et al. The Molecular Mechanisms of Action of Photobiomodulation Against Neurodegenerative Diseases: A Systematic Review , 2020, Cellular and Molecular Neurobiology.
[24] Tymish Y. Ohulchanskyy,et al. Red and near-infrared light evokes Ca2+ influx, endoplasmic reticulum release and membrane depolarization in neurons and cancer cells. , 2020, Journal of photochemistry and photobiology. B, Biology.
[25] T. Cassano,et al. The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy , 2020, International journal of molecular sciences.
[26] Janet Iwasa,et al. SynapsEM: Computer-Assisted Synapse Morphometry , 2020, bioRxiv.
[27] F. Benfenati,et al. Presynaptic L-Type Ca2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation , 2020, The Journal of Neuroscience.
[28] Quanguang Zhang,et al. Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation , 2020, Translational Neurodegeneration.
[29] R. Edwards,et al. The mechanism and regulation of vesicular glutamate transport: Coordination with the synaptic vesicle cycle. , 2020, Biochimica et biophysica acta. Biomembranes.
[30] Lesley A. McCollum,et al. Ultrastructural evidence for glutamatergic dysregulation in schizophrenia , 2020, Schizophrenia Research.
[31] Michael R Hamblin,et al. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review , 2019, Reviews in the neurosciences.
[32] Michael R Hamblin,et al. Transcranial Photobiomodulation Improves Cognitive Performance in Young Healthy Adults: A Systematic Review and Meta-Analysis. , 2019, Photobiomodulation, photomedicine, and laser surgery.
[33] S. Benedicenti,et al. The 808 nm and 980 nm infrared laser irradiation affects spore germination and stored calcium homeostasis: A comparative study using delivery hand-pieces with standard (Gaussian) or flat-top profile. , 2019, Journal of photochemistry and photobiology. B, Biology.
[34] P. McGuire,et al. Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View , 2019, Front. Psychiatry.
[35] Tymish Y. Ohulchanskyy,et al. Red and near‐infrared light induces intracellular Ca2+ flux via the activation of glutamate N‐methyl‐D‐aspartate receptors , 2019, Journal of cellular physiology.
[36] Michael R Hamblin,et al. Photobiomodulation for Alzheimer's Disease: Has the Light Dawned? , 2019, Photonics.
[37] R. Duman,et al. Neurobiology of rapid acting antidepressants: convergent effects on GluA1-synaptic function , 2019, Molecular Psychiatry.
[38] Hui Li,et al. The Role of NMDA Receptors in Alzheimer’s Disease , 2019, Front. Neurosci..
[39] S. Benedicenti,et al. Photobiomodulation Affects Key Cellular Pathways of all Life‐Forms: Considerations on Old and New Laser Light Targets and the Calcium Issue , 2018, Photochemistry and photobiology.
[40] L. Agnati,et al. Near‐infrared laser photons induce glutamate release from cerebrocortical nerve terminals , 2018, Journal of biophotonics.
[41] Michael R Hamblin,et al. Photobiomodulation and Cancer: What Is the Truth? , 2018, Photomedicine and laser surgery.
[42] Michael R Hamblin,et al. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation , 2018, Photochemistry and photobiology.
[43] Michael R Hamblin,et al. Brain Photobiomodulation Therapy: a Narrative Review , 2018, Molecular Neurobiology.
[44] K. Fuxe,et al. A2A‐D2 receptor–receptor interaction modulates gliotransmitter release from striatal astrocyte processes , 2017, Journal of neurochemistry.
[45] Stefano Benedicenti,et al. Photobiomodulation by Infrared Diode Laser: Effects on Intracellular Calcium Concentration and Nitric Oxide Production of Paramecium , 2016, Photochemistry and photobiology.
[46] Michael R. Hamblin,et al. Shining light on the head: Photobiomodulation for brain disorders , 2016, BBA clinical.
[47] J. Tuszynski,et al. Possible existence of optical communication channels in the brain , 2016, Scientific Reports.
[48] Michael R Hamblin,et al. Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis , 2016, Neurophotonics.
[49] Michael R. Hamblin,et al. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy , 2016, IEEE Journal of Selected Topics in Quantum Electronics.
[50] S. Benedicenti,et al. 808-nm laser therapy with a flat-top handpiece photobiomodulates mitochondria activities of Paramecium primaurelia (Protozoa) , 2016, Lasers in Medical Science.
[51] N. Mercuri,et al. Astrocyte-Dependent Vulnerability to Excitotoxicity in Spermine Oxidase-Overexpressing Mouse , 2016, NeuroMolecular Medicine.
[52] L. Agnati,et al. Calcium-permeable AMPA receptors trigger vesicular glutamate release from Bergmann gliosomes , 2015, Neuropharmacology.
[53] S. Benedicenti,et al. Effect of 808 nm Diode Laser on Swimming Behavior, Food Vacuole Formation and Endogenous ATP Production of Paramecium primaurelia (Protozoa) , 2015, Photochemistry and photobiology.
[54] Jiapei Dai,et al. Biophoton signal transmission and processing in the brain. , 2014, Journal of photochemistry and photobiology. B, Biology.
[55] Michael R. Hamblin,et al. Low‐level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro , 2014, Journal of biophotonics.
[56] N. Danbolt,et al. Glutamate as a neurotransmitter in the healthy brain , 2014, Journal of Neural Transmission.
[57] Jiapei Dai,et al. Spatiotemporal Imaging of Glutamate-Induced Biophotonic Activities and Transmission in Neural Circuits , 2014, PloS one.
[58] M. Marcoli,et al. Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X7-Evoked Glutamate Release. , 2013, ACS medicinal chemistry letters.
[59] B. Bianco,et al. Effects of an extremely low-frequency electromagnetic field on stress factors: a study in Dictyostelium discoideum cells. , 2013, European journal of protistology.
[60] A. Harvey,et al. Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders , 2013, Reviews in the neurosciences.
[61] A. Romano,et al. Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease , 2012, Neurobiology of Aging.
[62] Botros B. Kostandy. The role of glutamate in neuronal ischemic injury: the role of spark in fire , 2012, Neurological Sciences.
[63] G. Sanacora,et al. Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders , 2012, Neuropharmacology.
[64] William A Catterall,et al. Voltage-Gated Calcium Channels , 2011 .
[65] R. Bartha,et al. Reduced hippocampal glutamate in Alzheimer disease , 2011, Neurobiology of Aging.
[66] Thomas C. Südhof,et al. RIM Proteins Tether Ca2+ Channels to Presynaptic Active Zones via a Direct PDZ-Domain Interaction , 2011, Cell.
[67] Ben A. Barres,et al. Regulation of synaptic connectivity by glia , 2010, Nature.
[68] M. Marcoli,et al. Urotensin II receptor and acetylcholine release from mouse cervical spinal cord nerve terminals , 2010, Neuroscience.
[69] M. Marcoli,et al. Inhibition of Presynaptic Release-Facilitatory Kainate Autoreceptors by Extracellular Cyclic GMP , 2010, Journal of Pharmacology and Experimental Therapeutics.
[70] David G. Nicholls,et al. Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure , 2009, Journal of neurochemistry.
[71] Z. Qin,et al. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases , 2009, Acta Pharmacologica Sinica.
[72] M. Mattson,et al. Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease , 2008, Annals of the New York Academy of Sciences.
[73] R. Shigemoto,et al. Glutamate and GABA receptor signalling in the developing brain , 2005, Neuroscience.
[74] D. Javitt. Glutamate receptors as therapeutic targets , 2004, Molecular Psychiatry.
[75] H. Bellen,et al. The architecture of the active zone in the presynaptic nerve terminal. , 2004, Physiology.
[76] T. Südhof,et al. α-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis , 2003, Nature.
[77] J. Sánchez-Prieto,et al. Differential coupling of N- and P/Q-type calcium channels to glutamate exocytosis in the rat cerebral cortex , 2002, Neuroscience Letters.
[78] G. Zamponi,et al. Interactions between presynaptic Ca2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex. , 2001, Trends in pharmacological sciences.
[79] T. Ueda,et al. Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal , 2001, Journal of neurochemistry.
[80] T. Chase,et al. Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism , 2000, Trends in Neurosciences.
[81] F. Mora,et al. Effects of 4-Aminopyridine on Extracellular Concentrations of Glutamate in Striatum of the Freely Moving Rat , 1997, Neurochemical Research.
[82] J. Urenjak,et al. Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? , 1997, Journal of neurotrauma.
[83] J. Sánchez-Prieto,et al. Presynaptic Modulation of Glutamate Release Targets Different Calcium Channels in Rat Cerebrocortical Nerve Terminals , 1997, The European journal of neuroscience.
[84] Paul Greengard,et al. Distinct pools of synaptic vesicles in neurotransmitter release , 1995, Nature.
[85] R. Tapia,et al. Effect of 4-aminopyridine on transmitter release in synaptosomes , 1982, Brain Research.
[86] Michael R Hamblin. Mechanisms of photobiomodulation in the brain , 2019, Photobiomodulation in the Brain.
[87] Qianqian Fang,et al. Selective photobiomodulation for emotion regulation: model-based dosimetry study , 2019, Neurophotonics.
[88] P. Reddy,et al. Role of Glutamate and NMDA Receptors in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[89] Y. Moriyama,et al. Vesicular neurotransmitter transporters: an approach for studying transporters with purified proteins. , 2013, Physiology.
[90] Luis De Taboada,et al. Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice. , 2011, Journal of Alzheimer's disease : JAD.
[91] F. Chaudhry,et al. Pharmacology of neurotransmitter transport into secretory vesicles. , 2008, Handbook of experimental pharmacology.
[92] W. Mcentee,et al. Glutamate: its role in learning, memory, and the aging brain , 2005, Psychopharmacology.
[93] T. Sudhof,et al. The synaptic vesicle cycle. , 2004, Annual review of neuroscience.
[94] C. Garner,et al. The presynaptic cytomatrix of brain synapses , 2001, Cellular and Molecular Life Sciences CMLS.
[95] T. Südhof,et al. The Synaptic Vesicle Cycle in the Nerve Terminal , 1999 .
[96] D. Nicholls. Chapter 2 Presynaptic modulation of glutamate release , 1998 .